Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Safety and Effectiveness of SOFIA™/SOFIA™ PLUS When Used for Direct Aspiration as a First Line Treatment Technique in Patients Suffering an Acute Ischemic Stroke in the Anterior Circulation

NCT03417349 is registered in ClinicalTrials.gov with Dr. Markus Alfred Möhlenbruch as lead sponsor.

Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03417349 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Safety and Effectiveness of SOFIA™/SOFIA™ PLUS When Used for Direct Aspiration as a First Line Treatment Technique in Patients Suffering an Acute Ischemic Stroke in the Anterior Circulation
Lead sponsor
Dr. Markus Alfred Möhlenbruch
Phase
Observational
Overall status
Completed
Start date
October 1, 2017
Completion date
March 15, 2022
Enrollment
250 (actual)
Sites
15

Conditions

As the registry lists them; a condition with its own page is linked.

cerebral stroke, cerebrovascular stroke, stroke, acute